Note 15 - Subsequent Events (Details Textual) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 01, 2026 |
Jun. 30, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Proceeds from Issuance of Common Stock | $ 647,000 | $ 793,000 | ||
| Clearthink Capital Partners, LLC [Member] | ||||
| Stock Issued During Period, Shares, New Issues (in shares) | 3,250,000 | |||
| Subsequent Event [Member] | Clyra Medical [Member] | Secured Debt [Member] | ||||
| Debt Instrument, Interest Rate, Stated Percentage | 15.00% | |||
| Subsequent Event [Member] | Clyra Medical [Member] | Warrants Issued with Guaranteed Promissory Note [Member] | ||||
| Debt Instrument, Face Amount | $ 325,000 | |||
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ 7.5 | |||
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | 21,666 | |||
| Subsequent Event [Member] | Clearthink Capital Partners, LLC [Member] | ||||
| Stock Issued During Period, Shares, New Issues (in shares) | 3,500,000 | |||
| Proceeds from Issuance of Common Stock | $ 376,000 | |||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|